Navigation Links
A Combined Heart Pill-developed by Dr. Reddy’

Dr. Reddy’s, the Indian pharma giant has decided to join hands with the University of Auckland, //New Zealand to begin Global trials of a new fixed dose combination or “polypills” to prevent strokes and heart attacks.

The polypill will combine four drugs- aspirin, statin(to reduce cholesterol) and two drugs to prevent hypertension. The trial will check the reliability of the pill when it comes to safety and its effectiveness when consumed as one pill.

Investments of Dr. Reddy’s in the trial would come up to $7.5 million, and The Health Research Council, New Zealand has invested U.S. $241,055.

Dr. Reddy’s has initiated the trial six months ago, Satish Reddy, COO and managing director of Dr. Reddy’s said, “Since all medicines in the polypill are already prescribed to heart attack patients, we don’t anticipate any problem with polypill trial.”

Anyway, the plan of having a global trial will assess the success of using the polypill in different populations. The trial will begin by the second quarter of 2007, and would involve 600 people from five continents.

Apart from people from India and New Zealand, the other countries involved in the global trial would be South Africa, China, Australia, Brazil, the United Kingdom and the United States.

It took three years for the drug company to formulate this pill. Mr.Reddy’s claims this pill to be “single most important initiative of the decade” by his firm. He also said, “We should be able to introduce the drug for secondary indication [prescriptions to stroke/heart attack patients] by mid-2007.”

Affordability of the polypill

The cost of this pill is taken to prime importance since it is to be used in developing countries. Dr.Reddy’s assured, “Our intention is to see that one month’s medication costs less than Rs. 100 [U.S. $2.20]. The combination is not going to bring us big money, but it will help the patients as they get all four pills co mbined.”

Trials at Global Level

Professor Anthony Rodgers working at the University of Auckland’s, belonging to the clinical trials research unit is going to lead the trial. He has been an advisory to WHO and is also a world-renowned clinical trial expert.

Prof. Rodgers claims that this combined pill will prove to be more effective than four medicines. He said, “Research shows that people with chronic diseases, like heart disease, take only half their medications, they forget, or they feel well, so think they don’t need to take their pills. However, that creates a gap in their treatment, which can have serious consequences for some patients.”

Thus he believes that this oil is a more practical and easy solution to cardiac ailments.

Prof. Rodgers said that the first trial would involve 5000 people moderately prone to cardiac ailments. He said, “The first trial will confirm whether the polypill lowers blood pressure and cholesterol, if it goes ahead, this second trial would confirm the pill’s ability to prevent heart attacks and strokes.”
Source-Medindia
KOM
'"/>




Related medicine news :

1. Combined scan gives exact cancer diagnosis
2. A Protein-Rich Diet Combined With Exercise Found To Be More Effective In Weight Loss
3. Combined modality approach for effective treatment and enhanced survival in bile duct cancer
4. Vision Loss in Elderly Caused By Combined Effect of Genes and Bacterium
5. Exercise Combined with Dialysis Yields Better Results
6. Combined Anti-Fever Drug Therapy Proves Unsafe for Childhood Fever
7. A Combined Research for Producing Chlamydia Vaccine Begins
8. Combined Ingredients may Cut Cholesterol Levels
9. Combined Imaging Approach may Provide Better Identification of Difficult-to-diagnose Brain Clots
10. Combined Imaging Approach may Be Effective in Diagnosing Some Brain Clots
11. One in Three Heart Attack Patients Have No Chest Pains
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/19/2017)... ... January 19, 2017 , ... ... has recently unveiled impressive transportable capabilities with their iMedHD2™ Portable Teleultrasound ... extension to RMT technology that delivers HD, dynamic, streaming ultrasound images and video ...
(Date:1/19/2017)... ... 19, 2017 , ... WholeHealth is announcing their participation in ... Andrew Petersen and Trish Henrie-Barrus will be present Saturday and Sunday in the ... , “We know it’s easy to get carried away when you’re having ...
(Date:1/19/2017)... Scotch Plains, NJ (PRWEB) , ... January 19, ... ... a board certified dermatologist by the American Board of Dermatology and fellowship trained ... Institute of the National Institutes of Health, Dr. Li completed his internship in ...
(Date:1/19/2017)... ... 2017 , ... Bio-Optronics Inc. is proud to announce the ... to seamlessly integrate and streamline the way researchers prepare and conduct patient visits. ... and improving efficiency significantly for users – a first in the CTMS industry. ...
(Date:1/19/2017)... San Antonio, Texas (PRWEB) , ... January 19, 2017 , ... ... entering the GenCure Tissue Donation Awareness Scholarship competition., The winner will earn a $1,000 ... media accounts. The competition begins Feb. 1, and the deadline is May 31, with ...
Breaking Medicine News(10 mins):
(Date:1/20/2017)... LONDON , January 20, 2017 Avillion ... the appointment of Mark Weinberg , MD MBA as Chief ... , USA . ... Dr Weinberg has spent more than 17 ... "top 20" pharma companies to micro-cap biotech. Over the course of ...
(Date:1/19/2017)... NEW YORK , Jan. 19, 2017 ... the Ophthalmic Devices Market? Which areas are going to ... you potential revenues to 2026, assessing data, trends, opportunities ... charts, and graphs. Discover the most lucrative areas in ... study lets you assess forecasted sales across the all ...
(Date:1/19/2017)... , Jan. 19, 2017 Conference Call and Webcast to ... ) today announced it will release results for the fourth quarter ... ... host a conference call at 4:30 PM ET on Wednesday, February ... full year 2016 financial results and other corporate activities. To participate ...
Breaking Medicine Technology: